Model
Edge
Regeneron Pharmaceuticals, Inc.
0001681643
Filing type
144
Filing date
Feb 18, 2026
Updated
Feb 19, 2026 ยท 2:04 PM
Copy reference
Filing
144
Notice of Proposed Sale of Securities